UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q
(X) QUARTERLY REPORT PURSUANT TO SECTION 13 or 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended June 30, 1995
OR
( ) TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Commission File Number 1-815
E. I. du Pont de Nemours and Company
(Exact Name of Registrant as Specified in Its Charter)
Delaware 51-0014090
(State or Other Jurisdiction of (I.R.S. Employer
Incorporation or Organization) Identification No.)
1007 Market Street, Wilmington, Delaware 19898
(Address of Principal Executive Offices)
(302) 774-1000
(Registrant's Telephone Number)
Indicate by check mark whether the registrant (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Securities Exchange Act
of 1934 during the preceding 12 months (or for such shorter period that the
registrant was required to file such reports), and (2) has been subject to
such filing requirements for the past 90 days.
Yes X No
554,964,568 shares (excludes 24 million shares held by DuPont's Flexitrust)
of common stock, $0.60 par value, were outstanding at August 1, 1995.
1
<PAGE>
Form 10-Q
E. I. DU PONT DE NEMOURS AND COMPANY
Table of Contents
Page(s)
-------
Part I
Item 1. Financial Statements
Consolidated Income Statement ............................... 3
Consolidated Statement of Cash Flows ........................ 4
Consolidated Balance Sheet .................................. 5
Notes to Financial Statements ............................... 6-8
Item 2. Management's Discussion and Analysis of
Financial Condition and Results of Operations
Financial Results ........................................... 9
Industry Segment Performance ................................ 9-10
Consolidated Industry Segment Information ................... 11
Financial Condition ......................................... 12-13
Part II
Item 1. Legal Proceedings .................................... 14-16
Item 6. Exhibits and Reports on Form 8-K ..................... 16-17
Signature ....................................................... 18
Exhibit Index ................................................... 19
Exhibit 10.10 ................................................... 20-23
Exhibit 11 ...................................................... 24
Exhibit 12 ...................................................... 25
2
<PAGE>
<TABLE>
Form 10-Q
PART I. FINANCIAL INFORMATION
Item 1. FINANCIAL STATEMENTS
E. I. DU PONT DE NEMOURS AND COMPANY AND CONSOLIDATED SUBSIDIARIES
<CAPTION>
Three Months Ended Six Months Ended
CONSOLIDATED INCOME STATEMENT<Fa><Fb> June 30 June 30
- -----------------------------------------------------------------------------------------------------
(Dollars in millions, except per share) 1995 1994 1995 1994
- ----------------------------------------------------------------------------------------------------
<S> <C> <C> <C> <C>
SALES ............................................. $11,076 $10,161 $21,578 $19,351
Other Income ...................................... 253 278 614 483
------- ------- ------- -------
Total ......................................... 11,329 10,439 22,192 19,834
------- ------- ------- -------
Cost of Goods Sold and Other Expenses ............. 8,030 7,492 15,633 14,167
Selling, General and Administrative Expenses ...... 812 709 1,552 1,373
Depreciation, Depletion and Amortization .......... 642<Fc> 670 1,290<Fc> 1,373
Exploration Expenses, Including Dry Hole Costs
and Impairment of Unproved Properties ........... 88 53 142 112
Interest and Debt Expense ......................... 236 148 356 290
------- ------- ------- -------
Total ......................................... 9,808 9,072 18,973 17,315
------- ------- ------- -------
EARNINGS BEFORE INCOME TAXES ...................... 1,521 1,367 3,219 2,519
Provision for Income Taxes ........................ 583 575 1,322 1,085
------- ------- ------- -------
NET INCOME ........................................ $ 938 $ 792 $ 1,897 $ 1,434
======= ======= ======= =======
EARNINGS PER SHARE OF COMMON STOCK<Fd> ............ $ 1.70 $ 1.16 $ 3.07 $ 2.10
======= ======= ======= =======
DIVIDENDS PER SHARE OF COMMON STOCK ............... $ .52 $ .44 $ .99 $ .88
======= ======= ======= =======
See pages 6 to 8 for Notes to Financial Statements.
</TABLE>
3
<PAGE>
<TABLE>
Form 10-Q
<CAPTION>
Six Months Ended
CONSOLIDATED STATEMENT OF CASH FLOWS(a)(b) June 30
- ---------------------------------------------------------------------------------------------
(Dollars in millions) 1995 1994
- ---------------------------------------------------------------------------------------------
<S> <C> <C>
CASH PROVIDED BY OPERATIONS
Net Income ........................................................ $ 1,897 $ 1,434
Adjustments to Reconcile Net Income to Cash
Provided by Operations:
Depreciation, Depletion and Amortization ...................... 1,290 1,373
Dry Hole Costs and Impairment of Unproved Properties .......... 50 36
Other Noncash Charges and Credits - Net ....................... (47) (66)
Change in Operating Assets and Liabilities - Net .............. (862) (107)
------- -------
Cash Provided by Operations ................................. 2,328 2,670
------- -------
INVESTMENT ACTIVITIES
Purchases of Property, Plant and Equipment ........................ (1,482) (1,305)
Investment in Affiliates .......................................... (87) (43)
Proceeds from Sales of Assets ..................................... 185 128
Investments in Short-Term Financial Instruments - Net ............. 249 (824)
Miscellaneous - Net ............................................... (26) 91
------- -------
Cash Used for Investment Activities ......................... (1,161) (1,953)
------- -------
FINANCING ACTIVITIES
Dividends Paid to Stockholders .................................... (613) (603)
Net Increase in Borrowings ........................................ 6,022 7
Purchase of Treasury Stock ........................................ (8,347) -
Proceeds from Issuance of Common Stock through
Public and Private Offerings .................................... 1,747 -
Common Stock Issued in Connection with Compensation Plans ......... 35 75
------- -------
Cash Used for Financing Activities .......................... (1,156) (521)
------- -------
Effect of Exchange Rate Changes on Cash ............................. 70 78
------- -------
INCREASE IN CASH AND CASH EQUIVALENTS ............................... $ 81 $ 274
======= =======
See pages 6 to 8 for Notes to Financial Statements.
</TABLE>
4
<PAGE>
<TABLE>
Form 10-Q
<CAPTION>
CONSOLIDATED BALANCE SHEET<Fa><Fb> June 30 December 31
- -------------------------------------------------------------------------------------------------
(Dollars in millions, except per share) 1995 1994
- -------------------------------------------------------------------------------------------------
ASSETS
<S> <C> <C>
CURRENT ASSETS
Cash and Cash Equivalents ........................................ $ 937 $ 856
Marketable Securities ............................................ 254 253
Accounts and Notes Receivable .................................... 5,876 5,213
Inventories<Fe> .................................................. 4,361 3,969
Prepaid Expenses ................................................. 334 259
Deferred Income Taxes ............................................ 385 558
------- -------
Total Current Assets ........................................... 12,147 11,108
PROPERTY, PLANT AND EQUIPMENT, less accumulated depreciation,
depletion and amortization (June 30, 1995 - $28,378;
December 31, 1994 - $27,718) ..................................... 21,142 21,120
INVESTMENT IN AFFILIATES ........................................... 1,742 1,662
OTHER ASSETS ....................................................... 3,086 3,002
------- -------
TOTAL .......................................................... $38,117 $36,892
======= =======
LIABILITIES AND STOCKHOLDERS' EQUITY
CURRENT LIABILITIES
Accounts Payable ................................................. $ 2,717 $ 2,734
Short-Term Borrowings and Capital Lease Obligations .............. 7,842 1,292
Income Taxes ..................................................... 439 409
Other Accrued Liabilities ........................................ 3,243 3,130
------- -------
Total Current Liabilities ...................................... 14,241 7,565
LONG-TERM BORROWINGS AND CAPITAL LEASE OBLIGATIONS ................. 5,850 6,376
OTHER LIABILITIES .................................................. 8,514 8,438
DEFERRED INCOME TAXES .............................................. 1,714 1,494
------- -------
Total Liabilities .............................................. 30,319 23,873
------- -------
MINORITY INTERESTS IN CONSOLIDATED SUBSIDIARIES .................... 215 197
------- -------
STOCKHOLDERS' EQUITY
Preferred Stock .................................................. 237 237
Common Stock, $.60 par value; 900,000,000 shares authorized;
shares issued at June 30, 1995 - 734,664,688;
December 31, 1994 - 681,004,944 ................................ 441 408
Additional Paid-In Capital ....................................... 8,652 4,771
Reinvested Earnings .............................................. 8,689 7,406
Common Stock Held in Trust for Unearned Employee Compensation
and Benefits, at Market (Shares: June 30, 1995 - 24,000,000) .. (1,650) -
Common Stock Held in Treasury, at Cost (Shares: June 30, 1995 -
156,000,000) ................................................... (8,786) -
------- -------
Total Stockholders' Equity ..................................... 7,583 12,822
------- -------
TOTAL .......................................................... $38,117 $36,892
======= =======
See pages 6 to 8 for Notes to Financial Statements.
</TABLE>
5
<PAGE>
Form 10-Q
NOTES TO FINANCIAL STATEMENTS
(Dollars in millions, except per share)
[FN]
<Fa>These statements are unaudited, but reflect all adjustments that, in the
opinion of management, are necessary to provide a fair presentation of
the financial position, results of operations and cash flows for the
dates and periods covered. All such adjustments are of a normal
recurring nature. Certain reclassifications of 1994 data have been
made to conform to 1995 classifications.
<Fb>On April 6, 1995, the company acquired 156 million shares of its common
stock from Seagram for $56.25 per share. At June 30, 1995 these
shares are held by the company as treasury stock. Consideration
consisted of (i) $1,000 in cash, (ii) 90-day promissory notes totaling
approximately $7,300 and (iii) warrants valued at approximately $440
exercisable for 156 million shares of the company's common stock. In
general, the warrants allow Seagram to purchase 48 million DuPont
shares for a 60-day period ending on October 6, 1997 at a price of $89
per share; 54 million shares for a 60-day period ending on October 6,
1998 at a price of $101 per share; and 54 million shares for a 60-day
period ending on October 6, 1999 at a price of $114 per share. The
warrants are exercisable sooner in connection with certain significant
corporate events. The warrants are subject to various conditions,
including limitations on transfer to third parties.
Subsequent to April 6, 1995, the notes issued to Seagram were paid and
replaced by private-placement commercial paper borrowings of the
company. At June 30, 1995, the balance of borrowings related to the
Seagram transaction was $6,253 and the weighted-average interest rate
was 6.16 percent.
Also during the second quarter the company: (i) sold through public and
private offerings 27,339,375 shares of newly-issued common stock for
$1,747 and (ii) established a Flexitrust that will effect the sale or
distribution of common stock to satisfy existing employee compensation
and benefit programs. In May, DuPont issued 24 million shares of
common stock to the Flexitrust in return for a $1,612 promissory note
and $14 in cash. At June 30, 1995, 24 million shares, with a market
value of $1,650, were held by the Flexitrust. The Flexitrust is
classified as unearned compensation in Stockholders' Equity.
6
<PAGE>
Form 10-Q
Set forth below is a reconciliation of activity in Common Stock,
Additional Paid-In Capital, and the Flexitrust accounts from
January 1, 1995 through June 30, 1995:
1995
Shares Amount
Common Stock, $.60 par value 900,000,000
shares authorized, issued:
January 1 ............................ 681,004,944 $ 408
Issuance of shares in connection with:
Public and private offerings ....... 27,339,375 16
Flexitrust ......................... 24,000,000 14
Compensation plans ................. 2,320,369 3
June 30 .............................. 734,664,688 $ 441
=========== =======
Additional Paid-In Capital
January 1 .............................. $ 4,771
Changes due to:
Public and private offerings ......... 1,731
Common stock held by the Flexitrust .. 1,636
Compensation plans ................... 75
Issuance of warrants to purchase
common stock ....................... 439
June 30 .............................. $ 8,652
=======
Common Stock Held in Trust for Unearned
Employee Compensation and Benefits
(Flexitrust), at Market
January 1 .............................. - $ -
Establishment of Flexitrust ............ (24,000,000) (1,626)
Adjustment to market value ............. - (24)
June 30 .............................. (24,000,000) $(1,650)
=========== =======
<Fc>Effective with property, plant and equipment (PP&E) placed in service
beginning in 1995 for the company's nonpetroleum businesses, the
company changed from an accelerated method to a straight-line method
of depreciation. This change in accounting principle is being made to
reflect management's belief that the productivity of such PP&E will
not appreciably diminish in the early years of its useful life, and it
will not be subject to significant additional maintenance in the later
years of its useful life. In these circumstances, straight-line
depreciation is preferable in that it provides a better matching of
7
<PAGE>
Form 10-Q
costs with revenues. Additionally, the change to the straight-line
method will conform to predominant industry practice. This change did
not have a material impact for the first six months of 1995, and it is
not expected to have a material effect for full year 1995 results.
<Fd>Earnings per share are calculated on the basis of the following average
number of common shares outstanding:
Three Months Ended Six Months Ended
June 30 June 30
1995 550,445,989 615,537,673
1994 679,925,200 679,204,899
The 24 million shares held by the Flexitrust at June 30, 1995 are not
considered outstanding in computing the foregoing average shares
outstanding. Earnings per share calculations that reflect the impact of
common stock equivalents in the periods presented either are anti-
dilutive or do not result in materially dilutive primary or fully
diluted earnings per share.
Earnings per share for the six months ended June 30, 1995 of $3.07, do
not equal the sum of the first quarter's earnings per share ($1.40) and
the second quarter's earnings per share ($1.70) due to a significant
change in average common shares outstanding for the second quarter. See
Note (b) for a description of major common stock transactions in the
second quarter.
<Fe>Inventories June 30 December 31
----------- 1995 1994
------- -----------
Chemicals ................................. $ 321 $ 237
Fibers .................................... 744 677
Polymers .................................. 738 617
Petroleum ................................. 1,403 1,365
Diversified Businesses .................... 1,155 1,073
------ ------
Total ................................... $4,361 $3,969
====== ======
8
<PAGE>
Form 10-Q
Item 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL
CONDITION AND RESULTS OF OPERATIONS
(a) Results of Operations
(1) Financial Results:
The company had record earnings per share for the second
quarter of 1995 of $1.70, up 47 percent from the $1.16 earned in
the second quarter 1994. Excluding nonrecurring items, earnings
for the quarter were $1.75 per share. Net income totaled
$938 million, compared to $792 million earned in 1994.
Nonrecurring charges were recorded in both second quarter
periods -- $29 million after-tax or $.05 per share in 1995, and
$47 million after-tax or $.07 per share in 1994. The 1995 charge
reflects the current estimate of costs related to the recall of
"Benlate" DF 50 fungicide, partly offset by a reduction in
estimates for certain restructuring costs taken in prior periods.
During the second quarter, average shares outstanding were
substantially reduced, principally due to the redemption of DuPont
common stock from Seagram. Excluding the effect of accretion,
which totaled $.23 per share, both earnings per share and net
income increased 27 percent. The results continue to reflect
strong revenue gains and ongoing productivity improvements.
For the first six months of 1995, earnings per share
totaled $3.07 and exceeded 1994 previous record first-half earnings
per share by 46 percent. Net income for the first six months of
1995 was $1.9 billion compared to $1.4 billion in the same period
last year. Sales totaled $21.6 billion, up 12 percent.
During the first half, the company's chemicals and
specialties businesses grew revenue 13 percent and improved
productivity 8 percent, generating after-tax operating margins of
14 percent -- 30 percent higher than last year -- with Europe and
Asia recording the largest gains.
(2) Industry Segment Performance:
The following text compares second quarter 1995 results
with second quarter 1994 for each industry segment, excluding the
impact of nonrecurring items described in the footnotes to the
"Consolidated Industry Segment Information" table.
9
<PAGE>
Form 10-Q
Sales for the second quarter were $11.1 billion, up
9 percent from prior year. Petroleum segment sales were up
10 percent on higher refined product sales outside the United
States. Combined segments other than Petroleum were up
8 percent, with 2 percent higher volume and 6 percent higher
selling prices. Two-thirds of the increase in selling prices is
attributable to the weaker U.S. dollar.
o Chemicals segment earnings were $172 million, up
$71 million, or 70 percent, reflecting better results for
white pigments and specialty chemicals. Segment sales
increased 13 percent reflecting 3 percent higher sales
volume and 10 percent higher selling prices.
o Fibers segment earnings of $208 million were up
$31 million, or 18 percent, with the most significant
earnings improvement in aramids. Segment sales were
6 percent higher on 6 percent higher selling prices.
o Polymers segment earnings were $230 million, up
$47 million, or 26 percent, from last year reflecting
improved results in engineering polymers and elastomers.
Segment sales improved 14 percent, reflecting 5 percent
higher volume, and 9 percent higher selling prices.
o Petroleum segment earnings were $198 million, about the
same as last year. Upstream's results were $131 million,
down 14 percent, largely attributed to higher exploration
expenses. Higher crude oil prices during the period were
offset by lower international volumes and U.S. natural gas
prices. Downstream earnings were $67 million, up
40 percent, principally on lower costs in the United
States.
o Diversified Businesses segment earnings totaled
$320 million, up $65 million or 25 percent principally
reflecting earnings improvement from agricultural
products. Segment sales were up 2 percent due to
2 percent higher sales volume.
10
<PAGE>
<TABLE>
Form 10-Q
E. I. DU PONT DE NEMOURS AND COMPANY AND CONSOLIDATED SUBSIDIARIES
<CAPTION>
Three Months Ended Six Months Ended
CONSOLIDATED INDUSTRY SEGMENT INFORMATION June 30 June 30
- -----------------------------------------------------------------------------------------------------
(Dollars in millions, except per share) 1995 1994 1995 1994
- ----------------------------------------------------------------------------------------------------
<S> <C> <C> <C> <C>
SALES
- -----
Chemicals ........................................... $ 1,088 $ 959 $ 2,123 $ 1,807
Fibers .............................................. 1,832 1,722 3,686 3,367
Polymers ............................................ 1,844 1,619 3,621 3,102
Petroleum ........................................... 4,556 4,139 8,809 8,001
Diversified Businesses .............................. 1,756 1,722 3,339 3,074
------- ------- ------- -------
Total ........................................... $11,076 $10,161 $21,578 $19,351
======= ======= ======= =======
AFTER-TAX OPERATING INCOME
- --------------------------
Chemicals ........................................... $ 179<Fa> $ 101 $ 346<Fa>$ 184
Fibers .............................................. 235<Fa> 177 440<Fa> 321
Polymers ............................................ 230 183 465 330
Petroleum ........................................... 198 201 384 416
Diversified Businesses .............................. 257<Fb> 208<Fb> 494<Fb> 356<Fb>
------- ------- ------- -------
Total ........................................... 1,099 870 2,129 1,607
Interest and Other Corporate
Expenses Net of Tax ............................... (161) (78) (232) (173)
------- ------- ------- -------
NET INCOME .......................................... $ 938 $ 792 $ 1,897 $ 1,434
- ---------- ======= ======= ======= =======
<FN>
<Fa>The Chemicals and Fibers segments reflect a benefit of $7 and
$27, respectively, principally an adjustment of estimates
associated with the third quarter 1993 restructuring charge.
<Fb>Includes charges of $63 and $47 for quarters ended June 30, 1995
and 1994, respectively, associated with "Benlate" DF 50 fungicide
recall.
</TABLE>
11
<PAGE>
Form 10-Q
(b) Financial Condition at June 30, 1995
DuPont recorded a net cash inflow from operations of $2.3 billion
in the first half of 1995, as compared with $2.7 billion in the first half
of 1994. Inflows from higher net income were offset by outflows for
increased working capital, primarily accounts receivable-trade and inven-
tories. The first half increase in working capital reflects higher sales
overall, the seasonal pattern in certain businesses (principally crop
protection chemicals), and a weakening of the U.S. dollar during the period.
Capital expenditures for plant, property and equipment and invest-
ments in equity affiliates were $1.6 billion for the half, up approximately
$200 million from the same period last year. The company currently expects
capital expenditures to decrease from a planned $3.6 billion to a total of
$3.3 billion in 1995. In 1994, capital expenditures were $3.1 billion.
During the second quarter the company sold through public and
private offerings approximately 27.3 million shares of common stock for
$1.7 billion. Proceeds were used for repayment of a portion of the short-
term indebtedness incurred by the company in connection with the redemption
of 156 million shares of its common stock from Seagram. See Note(b) to the
Financial Statements for more information concerning the redemption of
shares from Seagram and financing activities during the second quarter.
Certain ratios are shown below:
At 6/30/95 At 12/31/94
---------- -----------
Debt Ratio (total debt to total
capitalization) 64% 37%
Current Ratio (current assets
to current liabilities) 0.85:1 1.5:1
Days' sales outstanding averaged 38 days in the second quarter,
unchanged from both the prior quarter and the second quarter of 1994. The
ratio of earnings to fixed charges was 7.1 for the first six months of 1995,
up from 6.1 for the year 1994.
Following the stock redemption from Seagram in April, Moody's
Investors Service (Moody's) lowered its rating on the company's senior long-
term debt to Aa3 from Aa2. The company's commercial paper rating was not
under review and was affirmed at Prime-1 by Moody's. Standard & Poor's
(S&P) lowered its rating on the company's senior debt and preferred stock to
AA- from AA and affirmed its commercial paper rating of A-1+. The ratings
outlook by S&P remains negative. The company does not expect that these
changes or any prospective change in its credit ratings as a result of the
12
<PAGE>
Form 10-Q
share redemption from Seagram will have a material impact on its interest
and debt expenses or on its access to borrowings. The company continues to
expect its Debt Ratio to return to its target range of 35 to 40 percent by
year end 1996.
As of June 30, 1995, the company's unused short-term bank credit
lines supporting its existing commercial paper program were $1,235 million.
A credit line was also established for a new private-placement commercial
paper program instituted in connection with the stock redemption from
Seagram in the amount of $4,830 million as of June 30, 1995. Unused
short-term bank credit lines outstanding as of June 30, 1995 were about
$6.2 billion.
As previously indicated, the company plans to sell about
$2 billion in assets to help finance the stock redemption from Seagram.
13
<PAGE>
Form 10-Q
PART II. OTHER INFORMATION
Item 1. LEGAL PROCEEDINGS
In 1991, DuPont began receiving claims by growers that use of
"Benlate" 50 DF fungicide had caused crop damages. Based on the belief that
"Benlate" 50 DF fungicide would be found to be a contributor to the claimed
damage, DuPont began paying claims. In 1992, after 18 months of extensive
research, DuPont scientists concluded that "Benlate" 50 DF was not
responsible for plant damage reports received since March 1991. Concurrent
with these research findings, DuPont stopped paying claims relating to those
reports. To date, DuPont has been served with more than 660 lawsuits by
growers who allege plant damage from using "Benlate" 50 DF fungicide. Fewer
than 200 of the lawsuits brought against the company since 1991 remain, the
rest having been disposed of by trial, dismissal or settlement. Several
matters are of note in 1995. In January, at the conclusion of a seven-month
trial in Kona, Hawaii, a jury awarded the plaintiff $23.9 million. DuPont
believes it has strong grounds for setting aside this adverse verdict on
appeal. In April 1995, a jury in federal court in Tallahassee, Florida,
found that "Benlate" was not defective and returned a verdict of no
liability for DuPont. Most recently, in state court in Miami, Florida,
DuPont was found liable for damages of $2.5 million. The trial court has
subsequently granted DuPont's motion for a new trial. Finally, a motion is
pending in federal court in Georgia asking that the judge award substantial
monetary sanctions against DuPont. DuPont would appeal any such award.
DuPont believes that "Benlate" 50 DF fungicide did not cause the alleged
damages and intends to prove this in ongoing matters.
Since 1989, DuPont has been served with approximately 100 home-
owner lawsuits in several jurisdictions, principally in Texas, Maryland,
Arizona, Colorado and New Jersey alleging damages as a result of leaks in
certain polybutylene plumbing systems. Numerous class actions, including
three nationwide actions, alleging the same damages have also been filed in
twenty states. In most cases, DuPont is a codefendant with Shell, Hoechst-
Celanese, and parts manufacturers. The polybutylene plumbing systems
consist of flexible pipe extruded from polybutylene connected by fittings
made from acetal. Shell Chemical is the sole producer of polybutylene; the
acetals are provided by Hoechst-Celanese and DuPont. It is not known how
many commercial and residential units nationwide have plumbing systems
containing acetals manufactured by DuPont. During 1994, DuPont settled a
majority of the Texas lawsuits in which it was a defendant. In these cases
DuPont will provide up to $34 million to cover approximately 64,000 claims.
Preliminary approval has been given to a settlement by DuPont of a nation-
wide class action pending in Alabama. The settlement is a part of the
company's efforts to achieve a nationwide resolution to this matter. Under
its terms, DuPont's potential funding commitment will not exceed 8% of
14
<PAGE>
Form 10-Q
replacement costs and actual damages and is limited to a total funding
commitment of $120 million. The court has certified the class action
against the other nonsettling defendants in the case. That certification is
under appeal. The total number of potential plaintiffs included in all
class actions filed has not been determined at this time. DuPont has not
been to trial in any case. Claims outside of litigation are handled by the
Plumbing Claims Group, a nonprofit corporation formed and funded by Shell,
Hoechst-Celanese and DuPont to carry out repairs to leaking polybutylene/
acetal plumbing systems.
The company's balance sheets reflect accruals for estimated costs
associated with these matters. Adverse changes in estimates of such costs
could result in additional future charges.
On October 24, 1988, the Louisiana Department of Environmental
Quality (LDEQ) issued a Compliance Order and Notice of Proposed Penalty to
Conoco Inc. for alleged violations of the Louisiana Hazardous Waste
Regulations. Following an inspection, LDEQ proposed a penalty of $165,000
for alleged violations related to the handling of by-product caustic and
other refinery waste management practices. Negotiations with LDEQ have
resulted in a preliminary agreement to settle the matter for payment of a
$45,000 civil penalty.
On October 18, 1991, the Environmental Protection Agency (EPA)
issued an Administrative Order under the Resource Conservation and Recovery
Act (RCRA) directing Conoco Pipeline Company (CPLC) to undertake specific
remedial measures related to a former oil reprocessing facility in Converse
County, Wyoming. CPLC contested the Administrative Order, and has taken
voluntary measures at the site together with other interested parties. On
February 19, 1993, the U.S. Department of Justice filed a lawsuit against 10
entities, including CPLC, to enforce the Order and collect penalties. CPLC
has settled this matter with the U.S. Government, and that settlement has
been approved by the Court. CPLC along with four other companies has agreed
to a cleanup of this site and to pay as a group $300,000 in civil penalties.
CPLC will pay a share of about 8% of the penalty and of cleanup costs.
Cleanup of the site, which may exceed $8.9 million in cost, is proceeding
pursuant to the settlement, and contribution has been obtained from the
majority of other potentially responsible parties. An action against the
site owner/operator is pending.
In April 1995, the EPA Region IV served on DuPont an Administra-
tive Complaint alleging the company's Circleville, Ohio plant had failed to
provide timely notice of a release of chlorine from the plant on January 30,
1993. The complaint seeks civil penalties of $125,000. DuPont has appealed
the complaint and is vigorously defending.
On May 30, 1995, DuPont received a complaint from the EPA alleging
that in 24 instances in 1990 and 1991, DuPont distributed or sold certain
benomyl fungicide products in violation of the Federal Insecticide,
Fungicide and Rodenticide Act. The EPA has proposed a civil penalty of
15
<PAGE>
Form 10-Q
$120,000. EPA's allegations are based on the contention that an analysis by
EPA in 1994 indicated that an impurity, which is part of DuPont's statement
of formula, had slightly exceeded an upper certified limit established by
EPA. DuPont believes the Agency's complaint is without merit and intends to
contest the matter.
Item 6. EXHIBITS AND REPORTS ON FORM 8-K
(a) Exhibits
The exhibit index filed with this Form 10-Q is on page 19.
(b) Reports on Form 8-K
1. The company filed a Current Report on Form 8-K, dated
April 7, 1995, in connection with Debt Securities that
may be offered on a delayed or continuous basis under
Registration Statements on Form S-3 (No. 33-48128 and
No. 33-53327). Through this Form 8-K, a copy of the
Registrant's Press Release, "DuPont Redeems 156 Million
Of Its Shares From Seagram For $8.8 Billion In Cash,
Notes, Warrants," dated April 6, 1995, was filed under
Item 2.
2. The company filed on April 13, 1995, a Current Report on
Form 8-K/A, Amendment No. 1, to its Form 8-K, dated
April 7, 1995. Through this Form 8-K/A, Amendment No.1,
the following documents were filed under Item 7:
(1) conformed copy of Agreement
(2) conformed copy of Warrant Agreement
(3) conformed copies of Warrant Certificates
(4) Form of Warrant Certificates
(5) conformed Registration Rights Agreement
(6) Form of Individual/Family Standstill Agreement
3. The company filed a Current Report on Form 8-K, dated
April 24, 1995, in connection with Debt and/or Equity
Securities that may be offered on a delayed or continuous
basis under Registration Statements on Form S-3
(No. 33-48128, No. 33-53327 and No. 33-58599). Through
this Form 8-K, a copy of the Registrant's Earnings Press
Release, dated April 24, 1995, was filed under Item 7.
4. The company filed a Current Report on Form 8-K, dated
April 27, 1995, in connection with Debt Securities that
may be offered on a delayed or continuous basis under
16
<PAGE>
Form 10-Q
Registration Statements on Form S-3 (No. 33-48128 and
No. 33-53327). Through this Form 8-K, a copy of the
Registrant's Press Release, dated April 26, 1995,
discussing a common stock dividend increase was filed
under Item 5.
5. The company filed a Current Report on Form 8-K, dated
June 15, 1995, in connection with Debt Securities that
may be offered on a delayed or continuous basis under
Registration Statement on Form S-3 (No. 33-53327). A
Form of Agency Agreement, A Form of Letter of Appointment
for Additional Agents and the Form of Notes, all to be
used as part of Medium-Term Note Series G were filed
under Item 7.
6. The company filed a Current Report on Form 8-K, dated
July 26, 1995, in connection with Debt and/or Equity
Securities that may be offered on a delayed or continuous
basis under Registration Statements on Form S-3
(No. 33-48128, No. 33-53327 and No. 33-60069). Through
this Form 8-K, a copy of the Registrant's Earnings Press
Release, dated July 26, 1995, was filed under Item 7.
17
<PAGE>
Form 10-Q
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of
1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorized.
E. I. DU PONT DE NEMOURS AND COMPANY
(Registrant)
Date: August 11, 1995
--------------------------------------
By /s/C. L. Henry
--------------------------------------
C. L. Henry
Senior Vice President - DuPont Finance
(As Duly Authorized Officer
and Principal Financial
and Accounting Officer)
18
<PAGE>
Form 10-Q
EXHIBIT INDEX
Exhibit
Number Description
- ------- -----------
10.10* Company's 1995 Corporate Sharing Plan, adopted by the Board of
Directors on January 25, 1995.
11 Computation of Earnings Per Common Share.
12 Computation of Ratio of Earnings to Fixed Charges.
*Management contract or compensatory plan or arrangement required
to be filed as an exhibit to this Form 10-Q.
19
<PAGE>
Form 10-Q
Exhibit 10.10
The 1995 Corporate Sharing Plan was adopted by the Board of
Directors of E. I. du Pont de Nemours and Company on January 25, 1995.
E. I. DU PONT DE NEMOURS AND COMPANY
1995 CORPORATE SHARING PLAN
I. PURPOSE
The purpose of this 1995 Corporate Sharing Plan (the "Plan") is to
offer employees a favorable opportunity to share in the success of E. I.
du Pont de Nemours and Company (the "Company") through stock options,
thereby giving them a stake in the growth and prosperity of the Company and
benefiting the Company.
II. FORM OF GRANTS
Grants under this Plan will be in the form of nonqualified stock
options to purchase shares of the Company's common stock.
III. LIMITATIONS ON GRANTS
1. The aggregate number of shares of the Company's stock which may be
made subject to stock options granted under this Plan shall not
exceed 12,000,000. The limitations set forth above shall be
subject to adjustment as provided in Article XII hereof.
2. No grants may be made under this Plan after December 31, 1995.
IV. ADMINISTRATION
1. Except as otherwise specifically provided, the Plan shall be
administered by the Compensation and Benefits Committee of the
Company's Board of Directors.
2. The Compensation and Benefits Committee is authorized, subject to
the provisions of the Plan, from time to time to establish such
rules and regulations as it deems appropriate for the proper
administration of the Plan, and to make such determinations and
take such steps in connection therewith as it deems necessary or
advisable, including amending the Terms and Conditions.
3. The decision of the Compensation and Benefits Committee with
respect to any questions arising as to interpretation of this
Plan, including the severability of any or all of the provisions
thereof, shall be final, conclusive and binding.
20
<PAGE>
Form 10-Q
4. Nothing in this Plan shall be deemed to give any employee, or any
employee's legal representatives or assigns, any right to
participate in the Plan except to such extent, if any, as the
Compensation and Benefits Committee may have determined or
approved pursuant to the provisions of this Plan.
V. ELIGIBILITY FOR GRANTS
1. Grants under this Plan may be made to employees of the Company as
determined by the Board of Directors.
2. The term "employee" may include an employee of a corporation or
other business entity in which this Company shall directly or
indirectly own fifty percent or more of the outstanding voting
stock or other ownership interest (the term "sharing plan company"
as used in this Plan shall mean a business entity whose employees
are eligible for grants under this Plan), but shall exclude any
director who is not also an officer or a full-time employee of a
sharing plan company. The term "optionee" as used in this Plan
means an employee to whom a stock option award has been granted
under this Plan or, where appropriate, his or her successor in
interest upon death.
VI. GRANTS
1. Any grant made to an employee shall be made by the Board of
Directors which shall take final action on any such grant.
2. Grants may be made at any time under this Plan and in the form
provided in Article II hereof.
3. The date on which a grant shall be deemed to have been made under
this Plan shall be the date of the Board of Directors authoriza-
tion of the grant or such later date as may be determined by the
Board of Directors at the time the grant is authorized. Each
optionee shall be advised in writing by the Company of a grant and
the terms and conditions thereof, which terms and conditions, as
the Board of Directors from time to time shall determine, shall
not be inconsistent with the provisions of this Plan.
VII. GRANT PRICE
The price per share of the Company's common stock which may be
purchased upon exercise of a stock option granted under this Plan shall be
determined by the Board of Directors, but shall in no event be less than the
21
<PAGE>
Form 10-Q
fair market value of such share on the date the stock option is granted, and
in no event less than the par value thereof. For purposes of the grant
price, fair market value shall be the average of the high and low prices of
the Company's common stock as reported on the "NYSE-Composite Transactions
Tape" on the date of grant of a stock option, or if no sales of such stock
were reported on said Tape on such date, the average of the high and low
prices of such stock on the next preceding day on which sales were reported
on said Tape. Such price shall be subject to adjustment as provided in
Article XII hereof.
VIII. OPTION TERM
The term of each stock option granted under this Plan shall be
for such period as the Board of Directors shall determine, but not for more
than ten years from date of grant.
IX. EXERCISE OF OPTIONS
1. Subject to the provisions of this Plan, each stock option granted
hereunder shall be exercisable on such date or dates and during
such period and for such number of shares as the Board of
Directors may determine. However, in no event shall a stock
option be exercisable prior to six months from date of grant.
The Board of Directors may fix from time to time a minimum number
of shares which must be purchased at the time a stock option is
exercised.
2. An optionee electing to exercise a stock option shall at the time
of exercise pay the Company the full purchase price of the shares
he or she has elected to purchase. Payment of the purchase price
shall be made in cash. With respect to shares of the Company's
common stock to be delivered upon exercise of a stock option, the
Compensation and Benefits Committee shall periodically determine
whether, and to what extent, such stock shall be in the form of
new common stock issued for such purposes, or common stock
acquired by the Company.
X. NONTRANSFERABILITY OF GRANTS
During an optionee's lifetime no stock option granted under this
Plan shall be transferable and stock options may be exercised only by the
optionee.
22
<PAGE>
Form 10-Q
XI. TERMINATION OF EMPLOYMENT
The Board of Directors shall determine the rules relating to
rights under stock options upon termination of employment.
XII. ADJUSTMENTS
1. In the event of any stock dividend, split-up, reclassification or
other analogous change in capitalization, the Compensation and
Benefits Committee shall make such adjustments, in the light of
the change, as it deems to be equitable, both to the optionees
and to the Company, in -
(a) the number of shares and prices per share applicable to
outstanding stock options,
(b) the aggregate limitation set forth in Article III with
respect to the number of shares which may be made subject to
options.
Furthermore, in the event of a distribution to common stock-
holders other than interim or year-end dividends declared as such
by the Board of Directors, the Compensation and Benefits
Committee shall make such adjustments, in the light of the
distribution, as it deems to be equitable, both to the optionees
and to the Company, in respect of the items described in (a)
above.
2. Any fractional shares resulting from adjustments made pursuant to
this Article shall be eliminated.
XIII. AMENDMENTS
The Company reserves the right to change this Plan in its discre-
tion by action of the Compensation and Benefits Committee or discontinue
this Plan in its discretion by action of the Board of Directors.
23
<PAGE>
<TABLE>
Form 10-Q
Exhibit 11
E. I. DU PONT DE NEMOURS AND COMPANY
CALCULATION OF EARNINGS PER SHARE<Fa>
(Dollars in millions, except per share)
<CAPTION>
Primary Fully Diluted
------------------------------ ------------------------------
Three Months Six Months Three Months Six Months
Ended Ended Ended Ended
June 30, 1995 June 30, 1995 June 30, 1995 June 30, 1995
------------- ------------- ------------- -------------
<S> <C> <C> <C> <C>
Net income less dividends on preferred stock ..... $ 935 $1,892 $ 935 $1,892
Interest expense, net of income tax, determined
under "Modified Treasury Stock Method" ......... 147 152 144 144
------ ------ ------ ------
Earnings applicable to common stock .............. $1,082 $2,044 $1,079 $2,036
====== ====== ====== ======
Average number of common shares outstanding
(excludes treasury stock and shares held by
DuPont Flexitrust) ............................. 550,445,989 615,537,673 550,445,989 615,537,673
Adjustments required for common share equivalents:
(1) shares awarded but undelivered under the
Variable Compensation Plan, (2) shares held by
the DuPont Flexitrust, and (3) shares assumed to
be issued due to stock options and warrants, net
of shares acquired, as determined under
"Modified Treasury Stock Method" ............... 88,620,350 47,665,232 88,653,366 48,497,284
----------- ----------- ----------- -----------
Adjusted average number of common shares ......... 639,066,339 663,202,905 639,099,355 664,034,957
=========== =========== =========== ===========
Earnings per share<Fb> ........................... $ 1.69 $ 3.08 $ 1.69 $ 3.07
====== ====== ====== ======
Earnings per share - as published ................ $ 1.70 $ 3.07 $ 1.70 $ 3.07
====== ====== ====== ======
<FN>
<Fa>There was no material change in common stock equivalents during the
first half of 1994 versus that presented in Form 10-K for the year
ended December 31, 1993, which indicated no material dilution in 1993
earnings per share.
<Fb>Calculations either result in dilution of less than 3% or are
antidilutive.
</TABLE>
24
<PAGE>
<TABLE>
Form 10-Q
Exhibit 12
E. I. DU PONT DE NEMOURS AND COMPANY
COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES
(Dollars in millions)
<CAPTION>
Six Months Ended Years Ended December 31
June 30, 1995 1994 1993 1992 1991 1990
<C> <C> <C> <C> <C> <C> <C>
Net Income .......................................... $1,897 $2,727 $ 566<Fa> $ 975<Fa> $1,403 $2,310
Provision for Income Taxes .......................... 1,322 1,655 392 836 1,415 1,844
Minority Interests in Earnings of Consolidated
Subsidiaries ...................................... 16 18 5 10 6 3
Adjustment for Companies Accounted for
by the Equity Method .............................. 16 18 41 6 35 29
Capitalized Interest ................................ (83) (143) (194) (194) (197) (161)
Amortization of Capitalized Interest ................ 78 154 144 101 94 84
3,246 4,429 954 1,734 2,756 4,109
Fixed Charges:
Interest and Debt Expense - Borrowings ............ 356 559 594 643 752 773
Adjustment for Companies Accounted for by the
Equity Method - Interest and Debt Expense ....... 37 55 42 62 11 9
Capitalized Interest .............................. 83 143 194 194 197 161
Rental Expense Representative of Interest Factor .. 59 118 143 151 162 163
535 875 973 1,050 1,122 1,106
Total Adjusted Earnings Available for Payment of
Fixed Charges ..................................... $3,781 $5,304 $1,927 $2,784 $3,878 $5,215
====== ====== ====== ====== ====== ======
Number of Times Fixed Charges are Earned ............ 7.1 6.1 2.0 2.7 3.5 4.7
====== ====== ====== ====== ====== ======
<FN>
<Fa>Income Before Extraordinary Item and Transition Effect of Accounting
Changes.
</TABLE>
25
<TABLE> <S> <C>
<ARTICLE> 5
<LEGEND>
This Schedule contains Summary Financial Information extracted
from Form 10-Q for the Quarterly Period ended June 30, 1995,
and is qualified in its entirety by reference to such financial
statements
</LEGEND>
<MULTIPLIER> 1,000,000
<S> <C>
<PERIOD-TYPE> 6-MOS
<FISCAL-YEAR-END> DEC-31-1995
<PERIOD-START> JAN-01-1995
<PERIOD-END> JUN-30-1995
<CASH> 937
<SECURITIES> 254
<RECEIVABLES> 5,876<F1>
<ALLOWANCES> 0
<INVENTORY> 4,361
<CURRENT-ASSETS> 12,147
<PP&E> 49,520
<DEPRECIATION> 28,378
<TOTAL-ASSETS> 38,117
<CURRENT-LIABILITIES> 14,241
<BONDS> 5,850
<COMMON> 441
0
237
<OTHER-SE> 6,905
<TOTAL-LIABILITY-AND-EQUITY> 38,117
<SALES> 21,578
<TOTAL-REVENUES> 22,192
<CGS> 15,633<F2>
<TOTAL-COSTS> 18,617<F3>
<OTHER-EXPENSES> 0
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 356
<INCOME-PRETAX> 3,219
<INCOME-TAX> 1,322
<INCOME-CONTINUING> 1,897
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> 1,897
<EPS-PRIMARY> 0
<EPS-DILUTED> 0
<FN>
<F1>Includes Other Accounts in addition to Notes and Accounts
Receivable-Trade
<F2>Includes Other Expenses
<F3>Cost of Goods Sold and Other Expenses; Depreciation, Depletion and
Amortization; Exploration Expenses, Including Dry Hole Costs and
Impairment of Unproved Properties; and Selling, General and
Administrative Expenses
</FN>
</TABLE>
